Pentoxifylline in prosthetic valve: a case report.

Aging Clin Exp Res

Section of Geriatrics, Department of Medicine, University of Verona, Verona, Italy.

Published: March 2019

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40520-018-0983-0DOI Listing

Publication Analysis

Top Keywords

pentoxifylline prosthetic
4
prosthetic valve
4
valve case
4
case report
4
pentoxifylline
1
valve
1
case
1
report
1

Similar Publications

Background: Peripheral arterial disease (PAD) may cause occlusions (blockages) in the main arteries of lower limbs. One treatment option is bypass surgery using autologous (the patient's own tissue) vein graft or prosthetic (artificial) graft. A number of factors influence occlusion rates in these patients, including the material used.

View Article and Find Full Text PDF

Evaluation of medicinal interventions for the management of oral submucous fibrosis: a systematic review of the literature.

J Contemp Dent Pract

November 2014

Professor, Department of Oral and Maxillofacial Surgical and Medical Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.

Oral submucous fibrosis is a chronic, progressive scarring disease associated with both significant morbidity including pain and limited mouth opening and an increased risk for malignancy. This systematic review evaluated the different medicinal (i.e.

View Article and Find Full Text PDF

Hemolysis associated with prosthetic heart valves: a review.

Cardiol Rev

June 2009

Department of Cardiology, The Dan Sheingarten Echocardiography Unit and Valvular Clinic, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel.

Article Synopsis
  • Hemolysis can be a serious complication of prosthetic heart valves, often linked to structural issues or leaks.
  • Mild hemolysis is common with mechanical valves, while severe cases are rare and suggest leaks around the valve.
  • Treatment options include medical therapies, transcatheter procedures, and surgery, with surgery being the preferred choice for severe cases.
View Article and Find Full Text PDF

This chapter about antithrombotic therapy for peripheral arterial occlusive disease is part of the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs, and Grade 2 suggests that individual patients' values may lead to different choices (for a full understanding of the grading see Guyatt et al, CHEST 2004;126:179S-187S). Among the key recommendations in this chapter are the following: For patients with chronic limb ischemia, we recommend lifelong aspirin therapy in comparison to no antiplatelet therapy in patients with clinically manifest coronary or cerebrovascular disease (Grade 1A) and in those without clinically manifest coronary or cerebrovascular disease (Grade 1C+).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!